Macro Finance
Sanofi Lines Up Takeover Target to Fix Pharma’s Lowest Valuation
Bloomberg Markets·November 20, 2026·1 min read
Sanofi is pursuing what would be the biggest takeover in the pharmaceutical industry in years, aiming to fix its lowest valuation among peers. The move comes as the company seeks to boost its pipeline and market position, with the target acquisition expected to address investor concerns about growth and profitability.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.